Evidence map›Paper›PMID 39662467›Full record

ArticleDevelopmental cell2025

Mast cells proliferate in the peri-hippocampal space during early development and modulate local and peripheral immune cells.

Alexa C Blanchard, Anna Maximova, Taylor Phillips-Jones, Matthew R Bruce, Pavlos Anastasiadis, Christie V Dionisos, Kaliroi Engel, Erin Reinl, Aidan Pham, Sonia Malaiya and 3 more

Abstract read
In one paragraph

Article in Developmental cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Developments in Mast Cell Research.The Journal of allergy and clinical immunology · 2026
    Review
  3. Mast Cells in the Developing Brain.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Alexa C BlanchardProgram in Molecular Medicine, University of Maryland School of Medicine, Baltimore, MD, USA; Medical Scientist Training Program, University of Maryland School of Medicine, Baltimore, MD, USA.
Anna MaximovaMedical Scientist Training Program, University of Maryland School of Medicine, Baltimore, MD, USA; Program in Neuroscience, University of Maryland School of Medicine, Baltimore, MD, USA.
Taylor Phillips-JonesDepartment of Pharmacology, University of Maryland School of Medicine, Baltimore, MD, USA.
Matthew R BruceDepartment of Pharmacology, University of Maryland School of Medicine, Baltimore, MD, USA.
Pavlos AnastasiadisDepartment of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, USA; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Medicine Institute for Neuroscience Discovery, University of Maryland, Baltimore, MD 21201, USA.
Christie V DionisosProgram in Neuroscience, University of Maryland School of Medicine, Baltimore, MD, USA.
Kaliroi EngelProgram in Neuroscience, University of Maryland School of Medicine, Baltimore, MD, USA.
Erin ReinlDepartment of Pharmacology, University of Maryland School of Medicine, Baltimore, MD, USA.
Aidan PhamProgram in Neuroscience, University of Maryland School of Medicine, Baltimore, MD, USA.
Sonia MalaiyaProgram in Neuroscience, University of Maryland School of Medicine, Baltimore, MD, USA.
Nevil SinghDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
Seth AmentInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA; Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA; Medicine Institute for Neuroscience Discovery, University of Maryland, Baltimore, MD 21201, USA.
Margaret M McCarthyDepartment of Pharmacology, University of Maryland School of Medicine, Baltimore, MD, USA; Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Medicine Institute for Neuroscience Discovery, University of Maryland, Baltimore, MD 21201, USA. Electronic address: mmccarthy@som.umaryland.edu.

Funding

UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANTP30CA134274 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI FEYRUZ VIRGILIA RASSOOL · 2008 to 2026
$51.0M
Neuroinflammation, Epigenetics and Male VulnerabilityR01MH052716 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI MARGARET M. MCCARTHY · 2000 to 2026
$9.6M
Signaling Pathways in Innate ImmunityT32AI095190 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Stefanie N. Vogel · 2012 to 2026
$4.7M
Mechanisms coordinating the local and systemic resistance to pathogensR01AI168192 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Nevil John Singh · 2023 to 2026
$2.3M
The impact of proliferating mast cells in the developing brainF30HD107942 · NICHD · UNIVERSITY OF MARYLAND BALTIMORE · PI BLANCHARD, ALEXA CIESINSKI · 2022 to 2025
$175k
A unique peri-hippocampal mast cell population drives neurodevelopmentF30MH135570 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI MAXIMOVA, ANNA ARKADIEVNA · 2023 to 2024
$82k
NCI NIH HHS P30 CA134274NIAID NIH HHS R01 AI168192NIAID NIH HHS T32 AI095190NICHD NIH HHS F30 HD107942NIMH NIH HHS F30 MH135570NIMH NIH HHS R01 MH052716
6 · The paper itself

Abstract

Brain development is a non-linear process of regionally specific epochs occurring during windows of sensitivity to endogenous and exogenous stimuli. We have identified an epoch in the neonatal rat brain defined by a transient population of peri-hippocampal mast cells (phMCs) that are abundant from birth through 2-weeks post-natal but absent thereafter. The phMCs are maintained by proliferation and harbor a unique transcriptome compared with mast cells residing in the skin, bone marrow, or other brain regions. Pharmacological activation of this population broadly increases blood-brain barrier permeability, recruits peripheral immune cells, and stunts local microglia proliferation. Examination of the post-mortem human brain demonstrated mast cells in the peri-hippocampal region of a newborn, but not an older infant, suggesting a similar developmental period exists in humans. Mast cells specifically, and early-life inflammation generally, have been linked to heightened risk for neurodevelopmental disorders, and these results demonstrate a plausible source of that risk.

Indexed as

Cell ProliferationHippocampusMast CellsAnimalsAnimals, NewbornBlood-Brain BarrierFemaleHumansInfant, NewbornMaleMicrogliaRatsRats, Sprague-Dawleyblood-brain-barrierCCL2hippocampal developmenthippocampusinflammationmast cellsmicrogliamonocytesneurodevelopmentproliferation

Identifiers

PMID39662467
PMCPMC11945645

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.